Recent UK decision in epic Neurim v Mylan patent battle may benefit generics seeking to stay injunctions
The country's courts continue to show great flexibility in an unusual dispute involving insomnia treatment Circadin
To read more
Register for limited access
Register to receive our weekly newsletter and access two of our subscriber-only articles per month.
Subscribe and start reading now
Subscribe for unlimited access to articles, in-depth analysis and research from the IAM experts.